Product Name

  • Name

    Amlodipine besylate

  • EINECS 1312995-182-4
  • CAS No. 111470-99-6
  • Article Data20
  • CAS DataBase
  • Density 1.227 g/cm3
  • Solubility Slightly soluble in water; sparingly soluble in ethanol
  • Melting Point 199-201 ºC
  • Formula C20H25ClN2O5.C6H6O3S
  • Boiling Point 527.2 ºC at 760 mmHg
  • Molecular Weight 567.06
  • Flash Point 272.6 ºC
  • Transport Information
  • Appearance White powder
  • Safety 26-36
  • Risk Codes 22-36/37/38-20/21/22
  • Molecular Structure Molecular Structure of 111470-99-6 (Amlodipine besylate)
  • Hazard Symbols HarmfulXn
  • Synonyms Amlodipine benzenesulfonate;Monopina;Amlodin;Norvas;3,5-Pyridinedicarboxylic acid,2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)- 1,4-dihydro-6-methyl-,3-ethyl 5-methyl ester,monobenzenesulfonate;3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl-5-methyl ester, monobenzenesulfonate;Myodura;Amcard;Tensivask;Norvasc (TN);3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, (+-)-, monobenzenesulfonate;Amdipin;Amlogard;Norvask;Antacal;3-Ethyl 5-methyl (+-)-2-((2-aminoethoxy)methyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, monobenzenesulfonate;Terloc;Astudar;benzenesulfonic acid; ethyl methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate;Norvasc;Cordarene;Cardiorex;
  • PSA 162.63000
  • LogP 5.30950

Synthetic route

4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-[2-phthalimidoethoxymethyl]-1,4-dihydropyridine
88150-62-3

4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-[2-phthalimidoethoxymethyl]-1,4-dihydropyridine

benzenesulfonic acid
98-11-3

benzenesulfonic acid

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
Stage #1: 4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-[2-phthalimidoethoxymethyl]-1,4-dihydropyridine With methylamine at 25℃; Large scale;
Stage #2: benzenesulfonic acid In water at 30℃; Temperature; Large scale;
91.6%
Stage #1: 4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-[2-phthalimidoethoxymethyl]-1,4-dihydropyridine With methylamine In water at 20 - 45℃; for 4.5h;
Stage #2: benzenesulfonic acid In water at 20℃; for 4.5h; pH=1 - 2; Product distribution / selectivity;
Stage #1: 4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-[2-phthalimidoethoxymethyl]-1,4-dihydropyridine With hydrazine In methanol; ethyl acetate at 34 - 37℃; for 0.05h; Inert atmosphere;
Stage #2: benzenesulfonic acid In isopropyl alcohol at 5 - 30℃; for 2h;
Stage #1: 4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-[2-phthalimidoethoxymethyl]-1,4-dihydropyridine With methylamine In dichloromethane at 25℃; for 4h;
Stage #2: benzenesulfonic acid In dichloromethane at 25℃;
48 g
amlodipine formate
246852-08-4

amlodipine formate

sodium phenylsulfonate
515-42-4

sodium phenylsulfonate

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
In water at 5 - 20℃; for 0.333333h; Product distribution / selectivity;90%
amlodipine chloroacetate
246852-11-9

amlodipine chloroacetate

sodium phenylsulfonate
515-42-4

sodium phenylsulfonate

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
Product distribution / selectivity;89%
amlodipine Hydrochloride

amlodipine Hydrochloride

sodium phenylsulfonate
515-42-4

sodium phenylsulfonate

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
In water at 10 - 20℃; for 0.833333h; Product distribution / selectivity;88%
2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine
88150-42-9

2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine

benzenesulfonic acid
98-11-3

benzenesulfonic acid

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
In methanol; toluene at 0 - 20℃; for 2h;87%
for 3h;
In isopropyl alcohol at 0 - 30℃; for 2 - 2.25h; Product distribution / selectivity;
amlodipine acetate
246852-10-8

amlodipine acetate

sodium phenylsulfonate
515-42-4

sodium phenylsulfonate

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
In ethanol; water at 5 - 20℃; for 0.5h; Product distribution / selectivity;83%
amlodipine nitrate
246852-13-1

amlodipine nitrate

sodium phenylsulfonate
515-42-4

sodium phenylsulfonate

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
Product distribution / selectivity;83%
amlodipine mesylate

amlodipine mesylate

sodium phenylsulfonate
515-42-4

sodium phenylsulfonate

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
Product distribution / selectivity;81%
N-tritylamlodipine
156366-27-7

N-tritylamlodipine

benzenesulfonic acid
98-11-3

benzenesulfonic acid

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
With ethanol for 4.66667h; Heating / reflux;
With methanol at 45℃; Kinetics; Reagent/catalyst; Temperature; Large scale reaction;
N-tritylamlodipine
156366-27-7

N-tritylamlodipine

benzenesulfonic acid
98-11-3

benzenesulfonic acid

A

diethyl 2,6-bis[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate
331258-31-2

diethyl 2,6-bis[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate

B

dimethyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
140171-66-0

dimethyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate

C

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
In methanol for 2h; Heating / reflux;
In methanol for 2h; Heating / reflux;
amlodipine hydrobromide
246852-09-5

amlodipine hydrobromide

sodium phenylsulfonate
515-42-4

sodium phenylsulfonate

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
In water for 0.333333h; Product distribution / selectivity;
ethyl 4-[2-(phthalimido)ethoxy]acetoacetate
88150-75-8

ethyl 4-[2-(phthalimido)ethoxy]acetoacetate

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: piperidine / toluene / 35 - 65 °C / Large scale
2.1: acetic acid / 25 °C / Large scale
3.1: methylamine / 25 °C / Large scale
3.2: 30 °C / Large scale
View Scheme
C27H29ClN2O5

C27H29ClN2O5

benzenesulfonic acid
98-11-3

benzenesulfonic acid

amlodipine besylate
111470-99-6

amlodipine besylate

Conditions
ConditionsYield
In cyclohexane; water at 0 - 60℃; Temperature;2.51 g
methanesulfonic acid
75-75-2

methanesulfonic acid

amlodipine besylate
111470-99-6

amlodipine besylate

amlodipine mesylate

amlodipine mesylate

Conditions
ConditionsYield
Stage #1: amlodipine besylate With sodium hydroxide In water; ethyl acetate for 0.666667h;
Stage #2: methanesulfonic acid In water; ethyl acetate at 0 - 5℃;
90%
amlodipine besylate
111470-99-6

amlodipine besylate

2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine
88150-42-9

2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine

Conditions
ConditionsYield
With sodium hydroxide In water for 0.5h; Heating / reflux;88.6%
With sodium hydroxide In tert-butyl methyl ether; water
With sodium hydroxide In methanol; water
With sodium hydroxide In water for 1h; Reagent/catalyst; Reflux;
bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

(Z)-1-chloroethyl 4-hydroxybut-2-enyl carbonate
1345092-27-4

(Z)-1-chloroethyl 4-hydroxybut-2-enyl carbonate

amlodipine besylate
111470-99-6

amlodipine besylate

(Z)-3-ethyl 5-methyl 2-(15-chloro-6,13-dioxo-2,7,12,14-tetraoxa-5-azahexadec-9-enyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
1345092-43-4

(Z)-3-ethyl 5-methyl 2-(15-chloro-6,13-dioxo-2,7,12,14-tetraoxa-5-azahexadec-9-enyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

Conditions
ConditionsYield
Stage #1: bis(trichloromethyl) carbonate; amlodipine besylate With triethylamine In dichloromethane at 20℃; for 1.5h;
Stage #2: (Z)-1-chloroethyl 4-hydroxybut-2-enyl carbonate In dichloromethane at 20℃; for 12h;
47%
toluene-4-sulfonic acid
104-15-4

toluene-4-sulfonic acid

amlodipine besylate
111470-99-6

amlodipine besylate

amlodipine p-toluene sulfonate
852990-75-1

amlodipine p-toluene sulfonate

Conditions
ConditionsYield
In methanol at 23℃; for 3h;
amlodipine besylate
111470-99-6

amlodipine besylate

amlodipine Hydrochloride

amlodipine Hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 23℃; for 3h;
D-tartaric acid
147-71-7

D-tartaric acid

amlodipine besylate
111470-99-6

amlodipine besylate

(S)-amlodipine-hemi-D-tartrate

(S)-amlodipine-hemi-D-tartrate

Conditions
ConditionsYield
Stage #1: amlodipine besylate With sodium hydroxide In tert-butyl methyl ether; water for 0.333333 - 0.5h;
Stage #2: D-tartaric acid In tert-butyl methyl ether; ISOPROPYLAMIDE at 30 - 72℃; for 2.16667h; Resolution of racemate;
With sodium hydroxide In tert-butyl methyl ether; ISOPROPYLAMIDE; water at 20 - 72℃; for 5.66667 - 6.41667h; Resolution of racemate;
D-tartaric acid
147-71-7

D-tartaric acid

amlodipine besylate
111470-99-6

amlodipine besylate

S(-) amlodipine hemi D(-) tartarate

S(-) amlodipine hemi D(-) tartarate

Conditions
ConditionsYield
Stage #1: amlodipine besylate With sodium hydroxide In tert-butyl methyl ether; water
Stage #2: D-tartaric acid In tert-butyl methyl ether; N,N-dimethyl acetamide at 20 - 72℃;
heptakis(6-(2-hydroxypropyl))-β-cyclodextrin

heptakis(6-(2-hydroxypropyl))-β-cyclodextrin

amlodipine besylate
111470-99-6

amlodipine besylate

C6H6O3S*C20H25ClN2O5*C63H112O42

C6H6O3S*C20H25ClN2O5*C63H112O42

Conditions
ConditionsYield
In water at 20℃; for 24h; Darkness;
β‐cyclodextrin
7585-39-9

β‐cyclodextrin

amlodipine besylate
111470-99-6

amlodipine besylate

C6H6O3S*C20H25ClN2O5*C42H70O35
156570-65-9

C6H6O3S*C20H25ClN2O5*C42H70O35

Conditions
ConditionsYield
In water at 20℃; for 24h; Darkness;
amlodipine besylate
111470-99-6

amlodipine besylate

amlodipine besylate

amlodipine besylate

Conditions
ConditionsYield
In potassium bromide for 192h; Irradiation;
amlodipine besylate
111470-99-6

amlodipine besylate

A

(-)-Amlodipine besylate
150566-71-5

(-)-Amlodipine besylate

B

(+)-Amlodipine besylate
828247-64-9

(+)-Amlodipine besylate

Conditions
ConditionsYield
With sodium dihydrogenphosphate; phosphoric acid In methanol; water pH=2.75; Reagent/catalyst; Ionic liquid; Resolution of racemate;
amlodipine besylate
111470-99-6

amlodipine besylate

[Mg(2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl esterbenzene sulfonate)(Cl)2(H2O)]

[Mg(2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl esterbenzene sulfonate)(Cl)2(H2O)]

Conditions
ConditionsYield
With magnesium(II) chloride hexahydrate In methanol; water at 75℃; for 3h;
amlodipine besylate
111470-99-6

amlodipine besylate

[Sr(2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl esterbenzene sulfonate)(Cl)2(H2O)]*2H2O

[Sr(2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl esterbenzene sulfonate)(Cl)2(H2O)]*2H2O

Conditions
ConditionsYield
With strontium (III) chloride hexahydrate In methanol; water at 75℃; for 3h;
amlodipine besylate
111470-99-6

amlodipine besylate

[Ba(2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl esterbenzene sulfonate)(Cl)2(H2O)]

[Ba(2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl esterbenzene sulfonate)(Cl)2(H2O)]

Conditions
ConditionsYield
With barium(II) chloride dihydrate In methanol; water at 75℃; for 3h;
amlodipine besylate
111470-99-6

amlodipine besylate

[Ca(2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl esterbenzene sulfonate)(Cl)2(H2O)]

[Ca(2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl esterbenzene sulfonate)(Cl)2(H2O)]

Conditions
ConditionsYield
With water; calcium chloride In methanol at 75℃; for 3h;
palladium dichloride

palladium dichloride

amlodipine besylate
111470-99-6

amlodipine besylate

[Pd(2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl esterbenzene sulfonate)2]Cl2

[Pd(2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl esterbenzene sulfonate)2]Cl2

Conditions
ConditionsYield
In methanol; water at 75℃; for 3h;
manganese(II) chloride tetrahydrate

manganese(II) chloride tetrahydrate

water
7732-18-5

water

amlodipine besylate
111470-99-6

amlodipine besylate

[Mn(2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl esterbenzene sulfonate)(Cl)2(H2O)]

[Mn(2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl esterbenzene sulfonate)(Cl)2(H2O)]

Conditions
ConditionsYield
In methanol at 75℃; for 3h;

Amlodipine besylate Specification

1.Introduction of Amlodipine besylate

The Amlodipine besylate, with its CAS NO.111470-99-6, is a kind of white powder. It has synonyms of  -Ethyl 5-methyl (+-)-2-((2-aminoethoxy)methyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, monobenzenesulfonate ; Amcard ; Amdepin ; Amdipin ; Amlodin ; Amlodipine benzenesulfonate ; Amlodipine besilate and ,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, (+-)-, monobenzenesulfonate. Amlodipine besylate should be stored in shady and cool warehouse and mainly used as pharmaceutical Intermediates.


2.Properties of Amlodipine besylate

(1) Melting Point: 199-201 °C  (2) solubility: DMSO: 20 mg/mL  (3) Flash Point: 272.6 °C
(4) Enthalpy of Vaporization: 80.17 kJ/mol  (5) Boiling Point: 527.2 °C at 760 mmHg
(6) Vapour Pressure of Amlodipine besylate:3.34E-11 mmHg at 25 °C

3.Structure descriptors of Amlodipine besylate

IUPAC Name: benzenesulfonic acid; 3-O-ethyl 5-O-methyl
2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,
4-dihydropyridine-3,5-dicarboxylate

InChI: InChI=1S/C20H25ClN2O5.C6H6O3S/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)
16(19(24)26-3)17(18)13-7-5-6-8-14(13)21;7-10(8,9)6-4-2-1-3-5-6/h5-8,17,
23H,4,9-11,22H2,1-3H3;1-5H,(H,7,8,9)

InChIKey: ZPBWCRDSRKPIDG-UHFFFAOYSA-N

Canonical SMILES : CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=
O)O
 

4.Safety data of Amlodipine besylate

Hazard Codes:HarmfulXn
Risk Statements: 22-36/37/38-20/21/22
R22:Harmful if swallowed.
R36/37/38:Irritating to eyes, respiratory system and skin.
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed.
Safety Statements: 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36:Wear suitable protective clothing.
WGK Germany: 3
RTECS of Amlodipine besylate (CAS NO.111470-99-6): US7967700
 

5.Toxity data of Amlodipine besylate

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo oral 10mg/kg (10mg/kg) SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: NAUSEA OR VOMITING
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 36, Pg. 1169, 1994.
man TDLo oral 1429ug/kg (1.429mg/kg) VASCULAR: SHOCK

KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"

LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
American Journal of Emergency Medicine. Vol. 16, Pg. 527, 1998.
mouse LD50 intraperitoneal 31mg/kg (31mg/kg)   Drugs in Japan Vol. -, Pg. 71, 1995.
mouse LD50 oral 37mg/kg (37mg/kg)   Drugs in Japan Vol. -, Pg. 71, 1995.
mouse LD50 subcutaneous 36mg/kg (36mg/kg)   Drugs in Japan Vol. -, Pg. 71, 1995.
rat LD50 intraperitoneal 42mg/kg (42mg/kg)   Drugs in Japan Vol. -, Pg. 71, 1995.
rat LD50 oral 393mg/kg (393mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BLOOD: OTHER CHANGES
Oyo Yakuri. Pharmacometrics. Vol. 42, Pg. 177, 1991.
rat LD50 subcutaneous 678mg/kg (678mg/kg)   Drugs in Japan Vol. -, Pg. 71, 1995.
women TDLo oral 1mg/kg (1mg/kg) CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION
Annals of Pharmacotherpy. Vol. 31, Pg. 853, 1997.
women TDLo unreported 6mg/kg/60D-I (6mg/kg) SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION Lancet. Vol. 341, Pg. 1102, 1993.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View